Alpha Bioresearch S.L.   Report issue

For profit Phase 4
Founded: Madrid Spain (2017)

Organization Overview

First Clinical Trial
2017
NCT04756310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Alpha Bioresearch S.L.